I believe HIV trial parameters are close to being set based on comments in the last company newsletter.My belief is they will wait on hepC trial results then head straight into HIV trials.
They have been slow on the release of information the past.But she will enjoy the highest rate of news flow in her history over the next 3/4 months.The SP(and oppies)will have an opportunity to appreciate over and beyond initial results.
She is starting from an incredibly low market cap $15mil with little opportunty to get set over the next month due to the long term and tightly held nature of the free float.
The numbers coming from Pharmasset's recent results were nothing short of spectactular($1.5 billion market cap added on the basis of a 15 patient trial).We're trialing 24 and safety is almost a non issue at this point.
She still has some risk but a $15mil market cap at this point in time..please..
What price on the back of successful HepC/HIV with so little freefloat available?
BIT Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
